ClinicalTrials.Veeva

Menu

The Trajectory of Fetal Alcohol Spectrum Disorders (FASD) Across the Life Span: Continuing Prevention and Longitudinal Epidemiology

University of North Carolina (UNC) logo

University of North Carolina (UNC)

Status

Completed

Conditions

Fetal Alcohol Spectrum Disorders

Treatments

Behavioral: Brief Motivational Enhancement Therapy (MET) Session
Behavioral: Informational Pamphlet

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT04026620
12-1827
5R01AA015134 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

Screen women of childbearing age (15 - 44 years) for high risk drinking in antenatal clinics of the established research sites in the Western Cape Province of South Africa (SA). While there are multiple reasons for this screening, the purpose is for selective (secondary) prevention of FASD. A.) Initiate a case control trial/efficacy study (n=400) of the use of one-session brief motivation enhancement therapy (MET) in busy public health settings (versus information only) in these rich research sites where very high rates of FASD have been documented over the entirety of the past two decades. B.) These targeted prevention activities follow both findings and staff experience in prevention over the past decade which indicate that the most likely venue for prevention activities is in antenatal clinics of the local, primary care clinics and hospitals. These activities will also provide tangible community-level pay back for participation in ongoing research activities and lay the groundwork for sustainable services going forward.

Full description

The purpose of the research is to find out if Motivational Enhancement Therapy is more effective than printed information alone (Informational pamphlets only) in helping women reduce their risk of giving birth to children with Fetal Alcohol Spectrum Disorders (FASD) at Primary Health Care Facilities, in addition to evaluation individuals for risky health behaviors by having them complete brief screening questionnaires that give them information of how much risk they might be facing from their alcohol or other drug use. When a pregnant mother drinks alcohol, she puts her baby at risk. FASD is a group of growth, mental, and physical problems that may occur in a baby when a mother drinks alcohol during pregnancy.

Enrollment

167 patients

Sex

Female

Ages

15 to 44 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Drinking pregnant women who are defined as women who:

    • Drank in the 3 months prior to pregnancy and/or
    • Drank alcohol at least once at any time during the prenatal period.
  • Gestational age less than or equal to 16 weeks, but not more than 20 weeks at intake

Exclusion criteria

  • Non-drinking pregnant women who are defined as women who have not had any alcohol during the past 30 days.
  • Gestational age >20 weeks

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

167 participants in 2 patient groups

Pamphlet-only
Other group
Description:
Pamphlet-only women will be provided with two (2) informational pamphlet(s) (both in Afrikaans).
Treatment:
Behavioral: Informational Pamphlet
MET Group
Other group
Description:
MET women will be provided with a one (1) hour and 30 minute session of Motivational Enhancement Therapy (MET) and informational pamphlet(s) (both in Afrikaans).
Treatment:
Behavioral: Informational Pamphlet
Behavioral: Brief Motivational Enhancement Therapy (MET) Session

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems